GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PhoenixBio Co Ltd (TSE:6190) » Definitions » EBITDA Margin %

PhoenixBio Co (TSE:6190) EBITDA Margin % : 0.00% (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is PhoenixBio Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PhoenixBio Co's EBITDA for the three months ended in Sep. 2024 was 円0 Mil. PhoenixBio Co's Revenue for the three months ended in Sep. 2024 was 円0 Mil. Therefore, PhoenixBio Co's EBITDA margin for the quarter that ended in Sep. 2024 was 0.00%.


PhoenixBio Co EBITDA Margin % Historical Data

The historical data trend for PhoenixBio Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhoenixBio Co EBITDA Margin % Chart

PhoenixBio Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.25 -16.50 -23.08 25.30 5.13

PhoenixBio Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.94 3.63 -2.86 2.94 -

Competitive Comparison of PhoenixBio Co's EBITDA Margin %

For the Biotechnology subindustry, PhoenixBio Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhoenixBio Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PhoenixBio Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PhoenixBio Co's EBITDA Margin % falls into.



PhoenixBio Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PhoenixBio Co's EBITDA Margin % for the fiscal year that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=87.937/1715.321
=5.13 %

PhoenixBio Co's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PhoenixBio Co  (TSE:6190) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


PhoenixBio Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of PhoenixBio Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PhoenixBio Co Business Description

Traded in Other Exchanges
N/A
Address
3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics related test, safety test, hepatitis virus (HBV / HCV) related drug efficacy test.

PhoenixBio Co Headlines

No Headlines